ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Eagle Pharmaceuticals Inc (CE)

Eagle Pharmaceuticals Inc (CE) (EGRX)

1.16
-0.01
(-0.85%)
Closed March 05 3:00PM

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2022 20152016201720182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 66.23M189.48M236.71M213.31M195.89M187.8M171.55M316.61M
Operating Income 2.56M51.6M68.26M38.56M21.82M32.95M2.77M80.96M
Pre Tax Income 2.57M53.43M72.95M34.04M22M22.68M-4.55M61.43M
Net Income 2.57M81.45M51.94M31.9M14.31M11.99M-8.63M35.64M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.1645.3153.4981.9331.050.918-0.6742.738
EBIT 2.56M53.35M73.99M38.56M22.52M24.69M-3.47M65.21M
EBITDA 2.67M53.19M79.25M42.23M25.31M36.53M6.53M92.98M